Ring Finger Protein 149 Is an E3 Ubiquitin Ligase Active on Wild-type v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)

• Published in: The Journal of biological chemistry 2012-07, Vol.287 (28), p.24017-24025
• Main Authors: Hong, Seung-Woo, Jin, Dong-Hoon, Shin, Jae-Sik, Moon, Jai-Hee, Na, Young-Soon, Jung, Kyung-Ah, Kim, Seung-Mi, Kim, Jin Cheon, Kim, Kyu-pyo, Hong, Yong Sang, Lee, Jae-Lyun, Choi, Eun Kyung, Lee, Jung Shin, Kim, Tae Won
• Format: Article
• Language: English
• Subjects: Blotting, Western; Cell Line, Tumor; Cell Survival; HCT116 Cells; HEK293 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology; Mitogen-Activated Protein Kinases - metabolism; Mutation; Proteasome Endopeptidase Complex - metabolism; Protein Binding - drug effects; Protein Degradation; Protein Synthesis and Degradation; Proto-Oncogene Proteins B-raf - genetics; Proto-Oncogene Proteins B-raf - metabolism; Raf; RNA Interference; Simvastatin - pharmacology; Tumor Suppressor Gene; Ubiquitin Ligase; Ubiquitin-Protein Ligases - genetics; Ubiquitin-Protein Ligases - metabolism; Ubiquitination; Ubiquitination - drug effects
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M111.319822

Members of the RAF family (ARAF, BRAF, and CRAF/RAF-1) are involved in a variety of cellular activities, including growth, survival, differentiation, and transformation. An oncogene encodes BRAF, the function of which is linked to MEK activation. BRAF is the most effective RAF kinase in terms of induction of MEK/ERK activity. However, the mechanisms involved in BRAF regulation remain unclear. In the present work, we used a tandem affinity purification approach to show that RNF149 (RING finger protein 149) interacts with wild-type BRAF. The latter protein is a RING domain-containing E3 ubiquitin ligase involved in control of gene transcription, translation, cytoskeletal organization, cell adhesion, and epithelial development. We showed that RNF149 bound directly to the C-terminal kinase-containing domain of wild-type BRAF and induced ubiquitination, followed by proteasome-dependent degradation, of the latter protein. Functionally, RNF149 attenuated the increase in cell growth induced by wild-type BRAF. However, RNF149 did not bind to mutant BRAF or induce ubiquitination thereof. Thus, we show that RNF149 is an E3 ubiquitin ligase active on wild-type BRAF. Background: BRAF is a downstream effector kinase of Ras. Results: RNF149, a RING finger domain-containing E3 ubiquitin ligase, is one of the several proteins shown to interact with wild-type BRAF by tandem affinity purification. Conclusion: RNF149 induces ubiquitination and subsequent proteasomal degradation of wild-type but not mutant BRAF. Significance: This is the first ubiquitin ligase shown to degrade wild-type BRAF in a proteasome-dependent manner.